NEULANDLAB NSE filing

Neuland Laboratories: Issues Letter of Confirmation for Lost Share Certificates

The RealCase readLow impact Neutral

Neuland Laboratories will issue a Letter of Confirmation for 100 shares reported lost by shareholder RAJESH KHANDWALA. This follows SEBI regulations for lost share certificates.

Why it matters

The issuance of a letter of confirmation for a small number of lost share certificates has a negligible impact on the company's overall operations or financial standing.

The market read

The announcement is a routine regulatory filing regarding lost share certificates and does not inherently signal positive or negative performance for the company.

Neuland Laboratories Limited has announced the issuance of a Letter of Confirmation in lieu of share certificates that were reported lost or misplaced by a shareholder.

This action is in compliance with Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and a relevant SEBI circular dated January 25, 2022.

The shareholder affected is RAJESH KHANDWALA, who holds 100 shares. The distinctive numbers for these shares range from 2750801 to 2750900. The corresponding Letter of Confirmation number is 58. The announcement was made on March 19, 2026.

Filing to action

What to do with a filing like this

Neuland Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.

That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.

See the model portfolios
Primary source

A plain-language summary of a public exchange filing by Neuland Laboratories Limited. Read the original for the full detail.

View original filing